2 resultados para energipolitiska mål
em QUB Research Portal - Research Directory and Institutional Repository for Queen's University Belfast
Resumo:
PURPOSE: To investigate whether failure to suppress the prostate-specific antigen (PSA) level to /=2 months of neoadjuvant luteinizing hormone-releasing hormone agonist therapy in patients scheduled to undergo external beam radiotherapy for localized prostate carcinoma is associated with reduced biochemical failure-free survival. METHODS AND MATERIALS: A retrospective case note review of consecutive patients with intermediate- or high-risk localized prostate cancer treated between January 2001 and December 2002 with neoadjuvant hormonal deprivation therapy, followed by concurrent hormonal therapy and radiotherapy was performed. Patient data were divided for analysis according to whether the PSA level in Week 1 of radiotherapy was 1 ng/mL in 52. At a median follow-up of 49 months, the 4-year actuarial biochemical failure-free survival rate was 84% vs. 60% (p = 0.0016) in favor of the patients with a PSA level after neoadjuvant hormonal deprivation therapy of 1 ng/mL at the beginning of external beam radiotherapy after >/=2 months of neoadjuvant luteinizing hormone-releasing hormone agonist therapy have a significantly greater rate of biochemical failure and lower survival rate compared with those with a PSA level of
Resumo:
The Amor-type near-Earth Asteroid (10302) 1989 ML has an “Earth-like” orbit (period 1.44 yr, eccentricity 0.14, inclination 4.4°), therefore the energy required to reach it from the Earth is relatively small making it a very attractive target for rendezvous missions. We have observed 1989 ML in the thermal infrared using the Spitzer Space Telescope, and compared these data with optical and near-infrared observations. The Spitzer results imply a diameter of 0.28±0.05 km and a geometric albedo of 0.37±0.15; together with the reflectance spectrum they are consistent with the relatively rare E classification.